Nagi Bioscience
About Nagi Bioscience
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 4717280 USD
- Last Funding: 2500000 EUR (Grant)
- Funding Status: Seed
Technology Stack
Nagi Bioscience actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology
Headquarters: Lausanne, Vaud, Switzerland
Leadership
- Matteo Cornaglia - CEO & founder LinkedIn